Enantioselective pharmacokinetics of primaquine in healthy human volunteers
| Autor: | Surendra Jain, Pius S. Fasinu, Donald F. Stanford, N. P. Dhammika Nanayakkara, Larry A. Walker, Travis W. Yates, Shabana I. Khan, H. M. T. Bandara Herath, James D. McChesney, Ikhlas A. Khan, Rajnish Sahu, Bharathi Avula, Narayan D. Chaurasiya, Mahmoud A. ElSohly, Babu L. Tekwani |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Spectrometry Mass Electrospray Ionization Primaquine Metabolite Primary Cell Culture Pharmaceutical Science Administration Oral Pharmacology chemistry.chemical_compound Antimalarials Structure-Activity Relationship Clinical report Pharmacokinetics medicine Humans Cells Cultured Chromatography High Pressure Liquid Detection limit Chromatography Molecular Structure Stereoisomerism Metabolism Middle Aged Enantioselective pharmacokinetics Healthy Volunteers chemistry Hepatocytes Enantiomer medicine.drug |
| Zdroj: | Drug metabolism and disposition: the biological fate of chemicals. 43(4) |
| ISSN: | 1521-009X |
| Popis: | Primaquine (PQ), a racemic drug, is the only treatment available for radical cure of relapsing Plasmodium vivax malaria and blocking transmission of P. falciparum malaria. Recent studies have shown differential pharmacologic and toxicologic profiles of individual PQ enantiomers in rodent, dog, and primate animal models. This study was conducted in six healthy adult human volunteers to determine the plasma pharmacokinetic profile of enantiomers of PQ and carboxyprimaquine (cPQ), the major plasma metabolite. The individuals were orally administered PQ diphosphate, equivalent to 45-mg base, 30 minutes after a normal breakfast. Blood samples were collected at different time intervals, and plasma samples were analyzed for enantiomers of PQ and cPQ. Plasma PQ concentrations were low and variable for both parent enantiomers and peaked around 2-4 hours. Peak (−)-(R)-PQ concentrations ranged from 121 ng/ml to 221 ng/ml, and peak (+)-(S)-PQ concentrations ranged from 168 ng/ml to 299 ng/ml. The cPQ concentrations were much higher and were surprisingly consistent from subject to subject. Essentially all the cPQ detected in plasma was (−)-cPQ. The peak concentrations of (−)-cPQ were observed at 8 hours (range: 1104-1756 ng/ml); however, very high concentrations were sustained through 24 hours. (+)-cPQ was two orders of magnitude lower than (−)-cPQ, and in a few subjects it was detected but only under the limit of quantification. In vitro studies with primary human hepatocytes also suggested more rapid metabolism of (−)-PQ compared with (+)-PQ. The results suggest more rapid metabolism of (−)-PQ to (−) cPQ compared with (+)-PQ. Alternatively, (+)-PQ or (+)-cPQ could be rapidly converted to another metabolite(s) or distributed to tissues. This is the first clinical report on enantioselective pharmacokinetic profiles of PQ and cPQ and supports further clinical evaluation of individual PQ enantiomers. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|